Gainers
• Happiness Biotech, Inc. HAPP shares surged 10.9% to $4.67 during Wednesday's regular session.
• Neos Therapeutics, Inc. NEOS shares moved upwards by 6.9% to $1.71.
• Lipocine, Inc. LPCN stock increased by 5.7% to $0.57.
• Aphria, Inc. APHA stock rose 5.5% to $5.61. According to the most recent rating by CiBC, on January 15, the current rating is at Neutral.
• Neoleukin Therapeutics, Inc. NLTX stock rose 4.7% to $11.63. The most recent rating by Piper Sandler, on January 10, is at Overweight, with a price target of $20.00.
• Elanco Animal Health, Inc. ELAN stock rose 3.7% to $31.77. According to the most recent rating by Raymond James, on January 10, the current rating is at Market Perform.
• Cronos Group, Inc. CRON stock surged 3.7% to $8.47. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
• Aurora Cannabis, Inc. ACB shares moved upwards by 3.0% to $2.05. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
Losers
• Evoke Pharma, Inc. EVOK stock fell 7.4% to $1.41 during Wednesday's regular session.
• Evolus, Inc. EOLS stock fell 6.4% to $10.45. The most recent rating by SVB Leerink, on November 26, is at Outperform, with a price target of $25.00.
• Adamis Pharmaceuticals, Inc. ADMP stock plummeted 6.3% to $0.72. According to the most recent rating by Raymond James, on November 26, the current rating is at Market Perform.
• Mallinckrodt, Inc. MNK stock decreased by 6.1% to $5.66.
• Guardion Health Sciences, Inc. GHSI stock decreased by 4.9% to $0.33.
• Assertio Therapeutics, Inc. ASRT shares decreased by 4.2% to $1.25.
• Neptune Wellness Solns, Inc. NEPT shares plummeted 4.2% to $2.95.
• SCYNEXIS, Inc. SCYX shares declined 3.8% to $1.01.
• TherapeuticsMD, Inc. TXMD shares decreased by 3.6% to $2.71.
• China SXT Pharmaceuticals, Inc. SXTC shares fell 3.3% to $0.84.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.